i
Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine
-
10 2019
-
-
Source: Antiviral Res. 170:104573
Details:
-
Alternative Title:Antiviral Res
-
Personal Author:
-
Description:No vaccines are currently licensed to prevent Crimean-Congo hemorrhagic fever virus (CCHFV) infection, which can cause mild self-limiting clinical signs or severe, often fatal hemorrhagic fever disease. Here we continued investigations into the utility of a single-dose virus replicon particle (VRP) vaccine regimen by assessing protection against Turkey or Oman strains of CCHFV. We found that all mice were completely protected from disease, supporting broad applicability of this platform for CCHFV prevention.
-
Keywords:
-
Source:
-
Pubmed ID:31377243
-
Pubmed Central ID:PMC6773275
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: